The Future of Medicine is Here: Butterfly Network Brings Ultrasound to the Home with TeleGuidance

GUILFORD, Conn., May 18, 2020 /PRNewswire/ — Butterfly Network has developed and is rolling out a new version of TeleGuidance™, their ultrasound-based telemedicine platform. TeleGuidance brings medical imaging to telemedicine. It leverages an array of leading-edge and easy-to-use augmented reality guiding tools. It allows trained practitioners to perform an ultrasound scan without being next to the patient.

“We are grateful for the FDA’s decisiveness during these challenging times. Butterfly TeleGuidance will transform telemedicine,” said Dr. John Martin, Butterfly’s Chief Medical Officer. “We will be able to bring the expertise of the physician to the patient instead of the other way around. This is critical in these times and extremely valuable for the future transformation of care.”

Doctors across the country are rapidly adopting telemedicine to minimize the spread of infection and protect patients from unnecessary exposure. This revolutionary new telemedicine platform can support imaging-based monitoring of COVID-19 patients and those with chronic conditions like congestive heart failure.

“Butterfly is here to democratize medical imaging. We know this is a difficult time for members of the healthcare community, who are either feeling the stress and risks of providing care during the pandemic, or facing a reduction in patients,” said Laurent Faracci, Butterfly’s Chief Executive Officer. “We believe that technology and innovation can make an immediate impact for good. To support the FDA’s new policies, we accelerated our efforts to build a breakthrough telemedicine solution for ultrasound at home under the prescription and supervision of a trained practitioner.”

Butterfly is starting with a limited release of the home-imaging platform to interested physicians and will roll-out the solution more broadly over the next few weeks. TeleGuidance is compatible with the latest generation of iOS devices. This is the latest of many new innovations released by Butterfly Network, in line with their mission to transform healthcare by democratizing medical imaging.

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole-body ultrasound system, Butterfly iQ, making ultrasound technology universally accessible and affordable. Butterfly Network’s mission is to democratize healthcare for the 4.7 billion people around the world lacking access to medical imaging. Through their patented Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions around the world.

CONTACT: media@butterflynetwork.com

 

View original content:http://www.prnewswire.com/news-releases/the-future-of-medicine-is-here-butterfly-network-brings-ultrasound-to-the-home-with-teleguidance-301060611.html

SOURCE Butterfly Network

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago